Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06620835
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-27
Brief Title:
Trial for Local Ablative Treatment LAT Optimization in Patients With Advanced Non-Small Cells Lung Cancer NSCLC Presenting an Anaplastic Lymphoma Kinase ALK Rearrangement Treated by Brigatinib
Sponsor:
Organization:
None